For patients who had at least 1 year of follow up after stopping antibiotics (pulmonary n = 21, non-pulmonary n = 14), 43% of patients with pulmonary infections achieved clinical cure and 79% of patients with non-pulmonary infections achieved clinical cure. Within 1 year of follow-up 19% of pulmonary infection patients and none of the non-pulmonary patients had died.
Background. 178 new cases of leprosy were reported in 2015 with Florida being one of six states and contributing a large number (72%) of registered cases. It was also the only state showing an increasing occurrence compared with the previous years. Studies from other southern U.S. states in armadillos and leprosy patients demonstrate infection with the same strain of Mycobacterium leprae, confirming human armadillo exposure as the main risk factor for leprosy. In contrast, cases from Florida show no clear risk factor. We present three cases of leprosy from Hillsborough county (Florida) with no previous armadillo exposure but a different risk factor in common: being foreign-born.
Methods. We report three cases of leprosy presenting in a non-endemic area of Florida during the past five years and highlight the absence of direct armadillo exposure as a risk factor for developing the disease.
Results. Case 1: A 35-year-old male from Mexico presented with multiple erythematous non-tender cutaneous lesions and numbness in both hands. He had a history of leprosy exposure from a Haitian inmate during incarceration in Florida. Biopsy confirmed borderline lepromatous leprosy.
Case 2: A 67-year-old female from Cuba presented with disseminated circular ulcerative lesions and severe hypesthesia of lower extremities. She denied leprosy or armadillo exposure. Diagnosis of borderline lepromatous leprosy was made through biopsy.
Case 3: A 38-year-old female from Puerto Rico presented with disseminated painless plaques, edema of the hands with numbness and paresthesias. She worked as a nurse but denied leprosy or armadillo exposure. A biopsy confirmed borderline lepromatous leprosy with erythema nodosum leprosum.
Conclusion. Our case series demonstrates that a history of armadillo exposure is not always present. Other risk factors need to be considered when leprosy is a possible diagnosis in a patient. Place of birth is a very important factor due to the diverse and increasing foreign-born population in the United States.
Disclosures. Background. The study compared rates of hospitalization between treatment groups in patients with nontuberculous mycobacterial lung disease (NTMLD) in a US national managed care claims database.
Methods. Patient (N = 1039) pharmacy claims at year 1 following NTMLD diagnosis were classified into 3 treatment groups including triple combo (macrolide + ethambutol + rifamycin ± other drugs) (G1), other antibiotics used by physicians for NTMLD (G2), and no treatment (G3). Hospitalization rates at year 2 were compared between treatment groups using mixed effects logistic regression to adjust for patient characteristics and comorbidities measured by Charlson Comorbidity Index (CCI) during the 12 months prior to NTMLD diagnosis (baseline).
Results. Mean age was 66, 66 and 73 years with 65%, 70% and 66% women in G1 (n = 353), G2 (n = 388) and G3 (n = 298) respectively. At baseline, there was no difference on CCI (CCI≈2) between treatment groups. However, comorbidity distribution differed prominently in asthma (22.1%, 26.3% and 11.4%), arrhythmia (19.3%, 19.3% and 27.2%), cystic fibrosis (0.8%, 4.6% and 0%), immune disorder (7.6%, 9% and 2.7%), pneumonia (49.0%, 41.8% and 32.6%), and tuberculosis (9.3%, 8.2% and 5.4%), and in immunosuppressant use (51%, 51.5% and 25.2%). Baseline hospitalization was 31.7% in G1, 33.0% in G2, and 25.8% in G3. At year 2, CCI stayed almost unchanged from the baseline scores (1.9 in G1, 2.0 in G2, and 1.9 in G3). Unadjusted hospitalization rates were 19.6%, 27.8% vs 20.8%, and adjusted rates were 44.5%, 56.1% and 47.8% in 3 groups respectively (Figure) . G2 had a 60% increase in risk of hospitalization after adjustment (odds ratio (OR)=1.60, 95% CI: 1.11-2.29, P = 0.01) compared with G1 but no statistically significant difference compared with G3 (OR=1.40, P = 0.08). Cerebrovascular disease (OR=1.8, P < 0.02), COPD (OR=1.60, P < 0.01), cystic fibrosis (OR=5.85, P < 0.01), depression (OR=1.64, P < 0.05), and other lung disease (OR=1.42, P < 0.05) were associated with a higher risk of hospitalization at year 2 after NTMLD diagnosis.
Conclusion. We observed a lower hospitalization rate in NTMLD patients receiving antibiotics that were concordant with first line ATS/IDSA guidelines recommendations in comparison with those who used other antibiotic regimens.
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